Haematology pathology Flashcards
15593 – Neutropenia may be associated with
1: cotrimoxazole therapy
2: systemic lupus erythematosus
3: polyarteritis
4: Addisonian (pernicious) anaemia
TTFT
Refer to Robbins, 6th Ed, Ch 15, page 646-647
13077 – Neutropenia may be associated with
1: thiouracil therapy
2: systemic lupus erythematosus
3: polyarteritis
4: Addisonian (pernicious) anaemia
TTFT
Patients with systemic lupus erythematosus have leukocyte autoantibodies causing neutropenia (B true). Agranulocytoses is encountered as an idiosyncratic reaction to a number of drugs including thouracil (A true) while the white cell share in the general reduction in cell cycling consequent on vitamin B12 deficiency (D true). Leukocytosis characterises the reaction in polyarteritis (C false).
24324 – Microcytic hypochromic anaemia
1: is due to iron deficiency
2: is common in females of menstrual age
3: may be associated with a lack of vitamin B6 (pyridoxine)
4: is a common complication of gastrectomy
TTFT
Robbins 6th ed. Pages: 449; 623; 629 Ch 14, p627-630
23754 – A marked increase in blood eosinophils often accompanies
1: Trichinella spiralis
2: Loeffler’s syndrome
3: systemic vasculitis
4: acute renal allograft rejection
TTTF
Robbins 6th ed. Pages: 648; 738 Roitt 9th ed. Pages: 277; 357
13082 – A marked increase in blood eosinophils often accompanies
1: hydatid disease
2: Loeffler’s syndrome
3: Delayed type hypersensitivity
4: Polyarteritis nodosa
TTFT
Eosinophilia characteristically accompanies a number of parasitic diseases, including hydatid disease (A true). It is a frequent concomitant of polyarteritis nodosa (D true) and Loeffler’s syndrome (B true), a transient condition associated with helminth infestation. It is not a feature of delayed hypersensitivity (C false).
13120 – Conditions predisposing to thrombosis include
1: polyarteritis nodosa
2: giant cell arteritis
3: Buerger’s disease
4: Takayasu’s disease
TTTT
Thrombosis is very likely in those diseases of the vessels in which the intima is inflamed. All four of the conditions listed show intimal inflammation (A,B,C,D true).
22764 – Antithrombin III
1: potentiates the action of PGI\b2 (prostacyclin)
2: deficiency causes recurrent phlebothrombosis
3: antagonises the actions of a wide spectrum of activated serum proteases
4: deficiency may be successfully treated with low dose heparin
FTTT
Robbins 5th ed. Pages: 100-101
15800 – Factors which tend to localise and limit thrombocoagulation (pathological or in response to injury) include
1: clearance of activated prothrombocoagulants
2: local degradation of clotting factors
3: local arterial/arteriolar constriction
4: secretion of protease inhibitors by adjacent intact endothelium
TTFT
This is the reinstatement of homeostatic mechanisms by the intact endothelium. Without these feedback mechanisms, any initiation of the protective or pathological thrombocoagulant state would progress inexorably.
23334 – Acute intravascular haemolysis, due to incompatible blood transfusion causes
1: decreased plasma haptoglobin level
2: methaemalbuminaemia
3: splenomegaly
4: obstructive hyperbilirubinaemia
TTFF
Robbins 5th ed. Chapter: 13 Pages: 587-588
21923, 13067 – Acute intravascular haemolysis is characteristically accompanied by
1: reduced level of serum haptoglobin
2: raised plasma haemoglobin
3: haemoglobinuria
4: methaemalbuminaemia
TTTT
Robbins 6th ed. CHAPTER: 14 PAGE: 606. Following acute intravascular haemolysis the binding power of the plasma (due to haptoglobin, haemopexin and albumin) is soon exhausted. The level of serum haptoglobin is thus reduced (A true). Haemoglobinuria soon follows, along with
methaemalbuminaemia (C and D true). Following acute intravascular haemolysis the plasma haemoglobin increases (B true).
13105 – Disseminated intravascular coagulation may cause the development of
1: haemolytic anaemia
2: renal failure
3: haemorrhagic diathesis
4: circulating anticoagulant substances
TTTT
The extensive intravascular coagulation associated with disseminated intra-vascular coagulation (DIC) consumes coagulation factors, and this is further exacerbated by the action of the fibrinolytic system. Thus DIC is associated with a haemorrhagic diathesis (C true). The deposition of fibrin within the microvasculature may lead to haemolytic anaemia (A true). Fibrinogen breakdown products include anticoagulant substances (D true). The events characterising DIC result in renal ischaemia, even to a degree of bilateral renal cortical necrosis, as can a number of the conditions which precipitate DIC (B true). A number of the conditions which may cause DIC, can themselves cause renal failure of other mechanisms.
15805 – Disseminated intravascular coagulation (thrombocoagulation) may cause
1: acute oliguric renal failure
2: haemorrhage
3: neutropenia
4: diffuse alveolar damage (adult respiratory distress syndrome)
TTFT
Responses 1 and 4 relate to the likelihood of thrombo-occlusive problems occurring as a result of formation of platelet-fibrin masses in the blood stream with resulting emboli in renal and/or pulmonary microcirculation. The spontaneous haemorrhage relates to the ‘consumptive’ component of DIC with consequent lack of platelets and coagulation proteins in the blood. WBC are not involved in the
‘consumption’.
23329 – Severe intravascular haemolysis may be seen as a complication of
1: clostridial infections
2: hereditary spherocytosis
3: lead poisoning
4: disseminated intravascular coagulation (thrombocoagulation)
TFFT
Robbins 5th ed. Chapter: 13 Pages: 587-588
22093 – Intravascular haemolysis may occur as a result of
1: alpha-thalassemia
2: Clostridium perfringens infection
3: mechanical heart valves
4: incompatible blood transfusion
FTTT
Robbins 5th ed. Chapter: 13 Pages: 586-587; 506-600
24184 – In Australia and New Zealand, donor blood for transfusion is screen-tested for markers of the following viruses
1: cytomegalovirus (CMV)
2: hepatitis B and C (HBV and HCV)
3: human immunodeficiency viruses (HIV 1/2)
4: Epstein-Barr virus (EBV)
FTTF
Blood Transfusion & Component Therapy ARC 1994 Page 3
15207 – For transfusion purposes, stored whole blood can be considered to
be a suitable clinical source of
1: oxygen-transportable haemoglobin
2: functional platelets
3: coagulation factors V and VIII
4: functional granulocytes
TFFF
Refer to Australian Red Cross NTBC Booklet, Jan 1994, supplement Feb 1998
7284 – In a patient undergoing massive transfusion, severe capillary-type oozing develops
1: blood for haemoglobin, platelet count, INR and APTT should be taken immediately
2: transfusion of platelets and fresh frozen plasma should await the assessment of the laboratory results
3: fresh frozen plasma is indicated even if INR and APTT are normal
4: if INR and / or APTT are prolonged, estimation of fibrinogen is important
5: fibrinogen deficiency may be corrected by administration of cryoprecipitate
6: capillary oozing, especially if accompanied by a falling blood pressure, may be a sign of a haemolytic transfusion reaction
TFFTTT